Kamada Ltd. (KMDA.TA)
Makes blood-derived medicines that prevent infectious diseases and treat immune disorders.
2,162.00+0.02%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-15.1%
The outlook
Kamada is trading near the lower end of its 52-week range and below both its 50- and 200-day moving averages, suggesting weak near-term momentum. Analyst coverage appears thin, and the overall sentiment leans bearish. The stock is valued at a trailing P/E of 20.2.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range22% of the way from its 52-week low to high
Market cap
$1.25B
52-wk high
2,890.00
52-wk low
1,956.00
50-day avg
2,182.68
200-day avg
2,390.54
Trailing P/E
20.2